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ABSTRACT 
 
OBJECTIVES. Retinoblastoma (Rb) represents the most frequent intraocular 
paediatric tumor, with an average incidence of 1:14’000 to 1:34'000 births. In 2006 
we were first to report on pineal cysts that appeared to be more common in children 
with hereditary bilateral Rb. The aim of our study was to review in a larger patient 
cohort the occurrence of pineal cysts and to study the link with disease 
characteristics and treatments received. 
METHODS AND PATIENTS. Observational retrospective study of clinical and 
radiological data of 103 patients treated for Rb who had undergone a cerebral 
magnetic resonance imaging (MRI) between 2006 and 2013 and had a follow-up. 
Clinical records were reviewed for sex, age at diagnosis, hereditary pattern of 
disease, tumor laterality, stage according to the International Classification of 
Retinoblastoma, age at first MRI, treatments received, date of first and last treatment 
and last follow-up, response to treatment, long-term outcome, time interval from 
diagnosis of Rb to the diagnosis of a pineal cyst, and genetic data if known. 
Radiological reports and brain images were reviewed for each patient with pineal cyst 
to record its size and change over time.  
RESULTS. Of 103 patients with Rb 56 had unilateral and 47 bilateral disease. 
Ninety-five were sporadic Rb while 8 were familial. Forty-nine MRIs out of 103 
(47.6%) presented a pineal cyst and were reviewed by a neuroradiologist to verify 
aspect and the size of the pineal gland. Occurrence of cysts was more frequent in 
bilateral disease, sporadic disease, in presence of a documented genetic mutation 
and in group D or E, but without statistically significance. No impact of treatment on 
the occurrence of cysts could be demonstrated. At 1 year of follow-up, cysts had 
higher growth in bilateral Rb and those with documented genetic mutation, but 
without statistical significance. None of the other parameters showed significant 
impact on growth.  
CONCLUSIONS. We found a high incidence of pineal cysts in Rb patients, but could 
not demonstrate a significant relationship to the hereditary subgroup or genetic 
mutation. The evolution was benign without malignant transformation in absence of 
atypical radiological signs. The higher incidence however compared to a healthy 
paediatric population clearly indicates that pineal cysts are part of the disease-related 
midline brain abnormalities.  
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INTRODUCTION 
 
Retinoblastoma (Rb) is a rare disease but represents the most frequent intraocular 
paediatric tumor, with an average incidence of 1:14'000 to 1:34'000 births1-4. It can 
occur as unilateral or bilateral disease. Bilateral Rb is always hereditary and is 
caused by a mutation of the RB1 gene. This gene is also responsible for other 
related abnormalities, such as malignant tumors of the pineal gland or other 
cancers5.   
 
Trilateral retinoblastoma (TRb) is a well-known entity constituted by a unilateral or 
bilateral Rb alongside with an intracranial midline primitive neuroectodermal tumor 
(PNET), which appears more frequently in the pineal gland6-9. These tumors are most 
often malignant pinealoblastomas. In 2006 we were first to report on pineal cysts that 
appeared to be more common in children with hereditary bilateral Rb10,11 compared 
to the healthy paediatric population12 (5.3% vs 1.8%) suggesting the possibility of a 
new entity, a benign variant of trilateral Rb that may be linked to the mutation, or to 
treatment-induced modifications (systemic chemotherapy, external beam 
radiotherapy). Since then various authors have observed the occurrence of benign 
pineal cysts in this patient population13-15. Along with considerable advances in the 
treatment of Rb in the field of conservative treatment modalities allowing a higher eye 
preservation rate without systemic chemotherapy and avoidance of radiotherapy, 
technological advances in MRI imaging have been obtained which allow a more 
precise visualization of the ocular and intracerebral structures and thus a better 
distinction between a begin cyst or a tumor of the pineal gland16. 
 
Patients with Rb have a risk of less than 0.5% to develop a TRb in sporadic unilateral 
disease, of 5-13% in sporadic bilateral disease and of 5-15% in familial bilateral Rb6. 
While Rb is in most cases curable17, TRb remains an often fatal high risk disease... 
Early detection provides a better chance of survival18. However, the usefulness of 
systematic MRI follow-up is still debated19. Less is known on the natural behaviour of 
benign pineal cysts. Since we kept the same imaging approach for our patients over 
the last 10 years, we decided to review the radiological behaviour of pineal cysts and 
to look for relationships to various clinical factors. 
 
 
METHODS 
 
This is an observational retrospective study of clinical and radiological data of 103 
patients treated for Rb who had undergone a cerebral magnetic resonance imaging 
between 2006 and 2013 and had a clinical and radiological follow-up (FU). MRI was 
performed in every patient at diagnosis. Patients with bilateral Rb had an annual 
follow-up until the age of six years for early detection of tumors of the pineal gland. 
Patients with unilateral disease were not followed by MRI if the initial imaging 
revealed no abnormality, being less at risk to develop a pinealoblastoma. Whenever 
a pineal cyst was identified, imaging was repeated every 3-6 months until non-
progression or absence of modification was secured (last MRI at FU). Cyst growth 
was evaluated based on first MRI, MRI at 1 year of FU and last MRI at FU.  
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Clinical records were reviewed for sex, age at diagnosis, the hereditary pattern 
(sporadic vs familial) of disease, tumor laterality (unilateral, bilateral), stage according 
to the International Classification of Retinoblastoma, date of first MR imaging, 
treatments received (systemic chemotherapy, local treatments, external beam 
radiotherapy), date of first and last treatment, and last follow-up, response to 
treatment (stable, favourable, unfavourable), long-term outcome (cure, death), time 
interval from diagnosis of Rb to the diagnosis of a pineal cyst diagnosis, and genetic 
data if known. 
 
Radiological reports were reviewed for each patient to record the aspect of the pineal 
gland. All patients had undergone the same MRI protocol: 3T MRI with sagittal or 
transverse unenhanced T1-weighted images or T2-weighted images and post-
contrast T1- weighted images. For those who had a pineal cyst described on the 
report, brain images were reviewed by the neuroradiologist involved in The European 
Retinoblastoma Imaging Collaboration (ERIC) group16. The pineal gland was 
measured in two planes and volume was calculated. The presence of a pineal cyst 
was classified according to the Classification of Pineal cysts in children under 5 years 
from the University Hospital of Essen made by the ERIC project (unpublished).  
 
 
STATISTICS 
 
The statistics analysis was done by a statistician from the Institute of Social and 
Preventive Medicine. The link between the presence or absence of cysts and the 
various items was tested by the Pearson's chi-squared test if all the cells of the table 
had a frequency of 5 patients minimum. If there were four or less patients in one 
category the Fisher's exact test was used.   
 
The link between the presence of cysts and age at diagnosis of Rb was tested by 
comparing the age of patients with cysts to those without cysts using the Mann-
Whitney test.   
 
Cyst size at the defined time points was compared, with the Mann Whitney test for 
groups for binary variables and with the Kruskal-Wallis test for groups that contained 
three or more categories in order to evaluate size growth over time. The link between 
age and cyst growth was estimated by the tau de Kendal correlation coefficient. 
 
We considered a significance threshold of alpha = 0.05. 
 
The risk of developing a pineal cyst (Table 2) was analysed using a logistic 
regression analysis. Groups were dichotomised (A-C vs D-E) to minimize the number 
of categories. The odds-ratio represents an estimation of the risk of having cysts for 
patients with Rb compared to a control group. OR>1 means that the risk is higher 
than the one of control group. OR<1 means that the risk is lower than the one of 
control group. For age, OR represents the risk for a patient with a certain age 
compared to a patient who is one year younger. The risk of the estimated value is 
higher (if OR>1) or lower (if OR<1) for each additional year of age. 
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RESULTS 
 
Patient characteristics (Table 1):  
There were 103 patients eligible for our study, 47 boys and 56 girls. Their mean age 
at diagnosis was 1.6 years. Of 103 patients with Rb, 56 had unilateral and 47 had 
bilateral disease, for a total of 113 eyes with the following distribution by disease 
Group:  Group A 4, Group B 20, Group C 13, Group D 54, Group E 22 eyes. Ninety-
five cases were sporadic and 8 were familial. Sixty-two out of 103 patients had 
available genetic results with RB1 mutation in 38/62 (62%). All patients had an MRI 
performed at diagnosis. Forty-nine out of 103 MRIs (47.6%) presented a pineal cyst 
and were reviewed by the neuroradiologist for size verification.  
 
Follow up: 
All patients had an ophthalmological FU at a defined time schedule according to their 
disease status and treatment, to secure cure and long-term FU. Analysis of the 
evolution of the cyst was possible in 43/49 cases with pineal cyst. Five out of 103 
patients died (4.9%). The first patient had a sporadic unilateral Rb treated with 
systemic chemotherapy. An MRI was performed for intraocular relapse, which 
revealed an asymptomatic pinealoblastoma of 2 x 2.5 cm. The child died from toxicity 
of high dose chemotherapy. Three other patients died from a progressive disease: 2 
presented an invasion of the central nervous system at diagnosis, and in 1 the 
parents refused enucleation after failure of conservative treatments. The fifth patient 
presented a sporadic bilateral Rb and was diagnosed with an atypical pineal cyst. A 
close MRI follow-up was recommended, but not performed. Nine months later the 
MRI revealed a pinealoblastoma, which responded only partially to intensive 
treatment and finally progressed.  
 
Pineal cysts (Table 2): 
The occurrence of pineal cysts was more frequent in bilateral Rb but without 
statistical significance compared to unilateral disease (chi squared test, p=0.296). 
Mean age at diagnosis of Rb for patients with cysts was 1.3 years and in those 
without cysts 1.9 years, which was not statistically significant (Mann Whitney test, 
p=0.184). The percentage of patients with cysts was higher when Rb was sporadic 
than familial (48.42% vs 37.50%), and in presence of a genetic mutation (55.26% vs 
33.33%), but without statistical significance. Although cysts were more common in 
more advanced disease stage such as Group D and E Rb, there was no difference to 
the less advanced disease groups A-C; for both disease group categories the risk to 
develop a cyst was equal with OR being 1.  
 
Treatments: 
The presence of cysts was not correlated to any treatment received (systemic 
chemotherapy, local treatments, radiotherapy), alone or combined. (Fisher’s exact, p 
= 0.916).  
 
Cyst growth (Table 3): 
At one year since first MRI, the cysts showed a mean and median growth of 1.5 mm 
each in unilateral Rb. In bilateral Rb, there was a mean growth of 18.4 mm and 
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median growth of 12 mm. The difference was statistically not significant. (Mann-
Whitney test, p=0.089). 
Cyst growth was also correlated to eye laterality, age at diagnosis of Rb, sporadic or 
familiar occurrence of Rb and genetic data. Only the latter seem to have had an 
impact on growth, as in presence of demonstrated genetic mutation the cysts showed 
a mean growth of 21.8 mm and median growth of 8.9 mm compared to those without 
genetic mutation, which on the contrary even showed a decreased mean growth of -
3.7 mm and median growth of -5.4 mm, without however reaching significance 
compared to absence of genetic mutation (Mann-Whitney test, p = 0.0682).  
We also looked at cyst growth at the last follow-up MRI (Table 4). When correlated to 
the same parameters such as unilateral vs bilateral Rb, age at diagnosis of Rb, 
sporadic vs familiar Rb, presence or absence of genetic mutation, none had a 
significant impact on growth.  
 
 
DISCUSSION 
 
This study describes a large cohort of Rb patients and reviews the occurrence of 
pineal gland cysts. The latter have increasingly been described for the past ten years 
and are part of the clinical picture observed in Rb patients. In our retrospective study, 
we found an incidence of pineal cysts of 47.6% on the baseline MRI performed at 
diagnosis of Rb. This is much higher than what has been described by other groups. 
Rodjan and al.9 reported a total incidence of pineal cysts of 5.4% and an incidence in 
the hereditary subgroup of 2.2%, which compares well with the incidence in a healthy 
paediatric population younger than five years of age which has an equivalent age 
frame as the Rb population20.  An explanation for this higher incidence in our patient 
cohort could be technical. High sensitivity 3T MRIs allow a much earlier and more 
precise detection of cystic modifications of the pineal gland. Another reason for 
detecting more pineal cysts could be improved expertise of the neuroradiologists 
involved in an European Retinoblastoma Imaging Collaboration (ERIC) composed of 
neuroradiologists from 5 participating countries (among them our neuroradiologist) 
who are working on a standardized description and classification of pineal cysts in Rb 
patients. 
 
As in our former study where we stated a higher incidence of pineal cysts in 
hereditary Rb11, we found in this larger patient cohort again a higher incidence in 
patients with bilateral disease and in those who had a documented genetic mutation, 
which is line with Abramson et al.14, but could not prove it statistically. On the 
contrary, we observed proportionally as many cysts in sporadic Rb as in familial 
cases (48.42% vs 37.50%). The extreme difference in numbers (95 sporadic vs 8 
familial) might be a reason for statistical non-significance. Furthermore, 40% of 
lacking genetic information and our small sample size could have biased our 
evaluation. A bigger patient number with genetic results might reveal a relationship to 
the occurrence of cysts, as the Rb population is known for various midline brain 
abnormalities in contrast to a normal paediatric population9 which could also include 
cysts as suggested earlier 10.  
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We looked at age at diagnosis of Rb and potential impact on developing cysts. No 
relationship could be found between age and presence of pineal cysts, as mean age 
at diagnosis of patients with cysts (1.3y) was not significantly different from those 
without cysts (1.9y). The occurrence of pineal cysts in the healthy paediatric 
population has been related to older age by several authors12,21. Whitehead and al.21 
retrospectively reviewed 3T MRIs of 100 healthy children aged from 1 month to 17 
years. They found a prevalence of 57% with an equal distribution through the ages, 
with a mean age of occurrence of 6.6 years and median age of 6 years.   
 
Although cysts were more common in more advanced disease stage such as group 
D or E Rb, there was no difference to the less advanced disease groups A-C. The 
risk to develop a cyst was the same as in a control group (OR 1).  
 
Shields et al. compared in 2001 142 patients having received systemic 
chemotherapy as treatment to 72 patients treated without chemotherapy: during 47 
months of follow-up, no intracranial neuroblastic tumor developed in the chemo 
reduction group22. We found no correlation either between the presence or absence 
of cysts and any kind of treatment the patients have received.  
 
As indicated in Table 3 an interesting finding in our analysis was the evaluation of 
cyst growth at 1 year after its diagnosis. Growth was higher in bilateral Rb, and in 
presence of genetic mutation. On the contrary, those without genetic mutation even 
showed a decrease in growth. At last follow-up MRI none of all parameters analysed 
influenced significantly growth. Whether the presence of a genetic mutation plays a 
role in the promotion of faster cyst growth at the beginning of its development only, or 
whether treatment-related factors could on the contrary be responsible of stabilization 
or decrease on size of the cysts, remains open. Longer patient FU is needed with 
regard of the rapidly moving treatment modalities for patients with Rb.   
 
According to Whitehead and al.21, cysts showed a trend of growth with increasing 
age which was not signifcant. They used three measures for pineal volume 
calculations in contrast to us who used only two ; furthermore their cohort did not 
focus on Rb patients as ours. Several other studies in healthy children did not 
report either changes in cyst growth over time with at least 6 months of FU11,13,14,23,24. 
Mandera et al. described cyst stability of 96% (23/24)25  over a mean follow up of 38 
months. As in our hands, cysts have also been reported to decrease14,21,23, or even 
resolve spontaneously13. 
 
Pineal cysts are benign and most of the time cause no symptoms14,20,21,23,25. Our 
study confirms that most of pineal cysts remain stable with time in children with Rb 
and are at low risk of progression. This speaks in favour of cysts as being benign 
entities. Only 1 patient presented an atypical pineal cyst at diagnosis of Rb with a 
cystic and solid part. In spite of the given recommendation to follow-up closely the 
cyst by MRI, the examination was repeated only 6 months later and revealed a 
malignant pineal tumor, which progressed after initial response to chemotherapy, 
with fatal outcome. 
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Literature reports variably on cysts and gender. Whitehead et al. observed cysts 
more frequently in girls than in boys, with a prevalence of 67% vs 57%21. Others 
found no gender predominance14. In our study we did not analyse this parameter that 
didn’t seem relevant to us in the context of Rb.  
 
The retrospective approach and incomplete data are the major limiting factors of our 
study not allowing confirming significance for some trends observed. In order to 
clarify the relationship of pineal cysts in Rb patients and their natural behaviour, 
further prospective studies are needed. Its high incidence however compared to a 
healthy paediatric population clearly indicates that pineal cysts are part of the 
disease-related midline brain abnormalities.  
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Table 1. Patient characteristics 
 
Variable Categories n (%) 
 
Gender 
 
Male 
 
47 (46.6) 
Female 
 
56 (54.4) 
 
Family History 
Negative (sporadic) 
 
95 (92.2) 
Positive (familial) 
 
8 (7.8) 
 
Laterality 
Unilateral 
 
56 (54.4) 
Bilateral 
 
47 (46.6) 
 
 
Genetic 
Genetic mutation 
 
38 (36.9) 
No genetic mutation 
 
24 (23.3) 
No genetic analysis 
 
41 (39.8) 
 
 
 
 
International 
classifcation 
Group A 
 
4 (2.67) 
Group B 
 
20 (13.34) 
Group C 
 
13 (8.67) 
Group D 
 
54 (36) 
Group E 
 
22 (14.67) 
No data 
 
37 (24.67) 
 
Pineal cyst 
Presence 
 
49 (47.6) 
Absence 54 (52.4) 
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Table 2. Pineal cysts and correlation to clinical characteristics 
 
Variable Category n 
with 
cysts 
(%) 
no adjustment adjustment to laterality 
OR IC à 95% P OR IC à 95% P 
Laterality 
unilat. (ref.) 56 24 (43) 1       
bilat. 47 25 (53) 1.52 0.69-3.51 0.3 
   
Eye   
bilateral (ref.) 47 25 (53) 1      
left 27 11 (41) 0.60 0.23-1.57 0.3 
   
right 29 13 (45) 0.61 0.28-1.81 0.48 
   
Age    0.861 0.69-1.08 0.19 0.88
1 0.69-1.11 0.286 
Family history 
negative 
(ref.) 95 46 (48) 1 
  1   
positive 8 3 ( 37.5) 0.64 0.14-2.83 0.555 0.51 0.11-2.36 0.386 
RB1 mutation 
absent. (ref) 24 8 (33) 1   1   
present 38 21 (55) 2.47 0.85-7.15 0.1 2.70 
0.63-
11.64 0.183 
Left eye 
D, E  (ref)  37 18 (49) 1   1   
A, B ou C 20 8 (40) 0.70 0.23-2.12 0.532 0.70 0.21-2.31 0.557 
Right eye 
D, E  (ref)  43 23 (53) 1   1   
A, B ou C 17 6 (35) 0.47 0.15-1.51 0.2 0.47 0.14-1.57 0.220 
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Table 3. Mean and median growth at one year MRI 
 
 n mean 
growth 
sd median 
growth 
igr min max p 
Bilateral 
 
14  18.39868   27.67028    12.0483    27.2906      -6.93    92.1788  
0.089
0 Unilateral 
 
9 1.520611   11.50436     1.4841    18.3139   -14.6766     14.354 
Left eye 
 
5 5.2912 8.97059      8.168    15.8364     -5.442    13.8226  
0.185
2 Right eye 
 
4 -3.192625   13.86809   -6.22395   22.2233
5   
-14.6766     14.354 
Sporadic 
 
23 11.79422   23.90585      8.168    20.5193   -14.6766    92.1788  
Familial 
 
0 - - - - - - - 
Genetic 
mutation 
13 14.44449   25.48145     8.9234    19.3723    -5.8341    92.1788  
 
0.068
2 
No 
genetic 
mutation 
5 -3.74878   11.85452     -5.442    15.4161   -14.6766    13.8226 
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Table 4. Mean and median growth at last follow-up MRI 
 
 
 
n Mean 
growth 
sd Median 
growth 
igr min max p 
Bilateral 
 
22 21.84826   33.89725   10.70295    29.0599    -8.0992   135.0666  
0.1348 
 Unilateral 
 
18 5.757278   10.83305    1.81355    18.0288   -11.7379    22.8824 
Left eye 
 
10 6.81202   10.75394    5.46215    15.4626 -6.7596    22.8824  
0.3156 
 Right eye 
 
8 4.43885   11.52128      0.5087    19.5863   -11.7379    18.8795 
Sporadic 
 
37 14.05162   26.74657     7.9348     20.267   -11.7379   135.0666  
0.9795 
Familial 
 
3 21.4609   37.29516     7.5586    70.5967    -6.8863    63.7104 
Genetic 
mutation 
19 18.11905   33.07184     7.9348 28.8279    -6.8863   135.0666  
0.4451 
No 
genetic 
mutation 
6 6.496433     6.496433   1.62275     18.8126    -5.9773     22.764 
 
 
 
 
 
 
